Conavi Medical Retains BND Projects Inc. for Corporate Development Services
February 04, 2025 16:30 ET | Source: Conavi Medical Corp. TORONTO, Feb.…
IRIS 9MYoY Revenues up 29%, 9MYoY Net profits up 155%
NAVI MUMBAI, India, Jan. 31, 2025 /PRNewswire/ -- An impressive 29% YoY growth…
INFIDIGIT UNVEILS INFIGROWTH – AN SEO PLATFORM – AT INDIA SEO CONFERENCE 2025
EXCLUSIVE LAUNCH EVENT WITNESSES OVERWHELMING ENTHUSIASM FROM THE SEO COMMUNITY MUMBAI, India,…
India Influencer Conclave Chapter 3 comes to Ahmedabad
AHMEDABAD, India and GURGAON, India, Jan. 30, 2025 /PRNewswire/ -- The year…
Adswerve Certified as Early Google Meridian Partner
DENVER, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Adswerve, a leading data, media,…
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…
Coca-Cola India Southwest Asia Announces New Vice-President of Customer & Commercial Leadership
NEW DELHI, Jan. 23, 2025 /PRNewswire/ -- Coca-Cola India Southwest Asia (INSWA) Operating…
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…
Coca-Cola India Southwest Asia Announces New Vice-President of Customer & Commercial Leadership
NEW DELHI, Jan. 23, 2025 /PRNewswire/ -- Coca-Cola India Southwest Asia (INSWA) Operating…
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…